Check-Cap Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEK research report →
Price Chart
About the company
Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays.
- CEO
- David Lontini
- IPO
- 2015
- Employees
- 85
- HQ
- Isfiya, IL
Get TickerSpark's AI analysis on CHEK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.88M
- P/E
- 0.70
- Fwd P/E
- 0.30
- PEG
- 0.01
- P/S
- 0.00
- P/B
- 0.84
- EV/EBITDA
- 0.75
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 416.71%
- ROIC
- -68.72%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-161,000+24.1%
- Op Income
- $-25,949,000
- Net Income
- $-25,149,000-43.2%
- EPS
- $-4.30-43.3%
- OCF Growth
- +100.0%
- FCF Growth
- +100.0%
- 52W High
- $3.13
- 52W Low
- $0.56
- 50D MA
- $1.72
- 200D MA
- $1.08
- Beta
- 0.46
- RSI (14)
- 51
- Avg Volume
- 2.99M
No earnings-call transcripts are available for CHEK yet.
- Free Float
- 95.0%
- Shares Outstanding
- 5.85M
- Float Shares
- 5.56M
of shares held by institutions
18 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| American Portfolios Advisors | 9.10K | 0 |
Our CHEK coverage
Recent articles, reports, and earnings notes.
No research on CHEK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHEK report →Accuray (NASDAQ:ARAY) & Check-Cap (NASDAQ:CHEK) Critical Analysis
defenseworld.net · Jan 3
MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company
newsfilecorp.com · Nov 17
MBody AI ($CHEK) Expands Global Leadership in Embodied AI With Major Wins
newsfilecorp.com · Nov 10
RETRANSMISSION: Check-Cap and MBody AI Advance Toward Closing Transformational Merger
newsfilecorp.com · Nov 6
Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
prnewswire.com · May 14
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
prnewswire.com · May 13
Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
prnewswire.com · May 8
Why Is Check-Cap (CHEK) Stock Up 44% Today?
investorplace.com · Mar 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.